The Role of Short-Chain Fatty Acids, Particularly Butyrate, in Oncological Immunotherapy with Checkpoint Inhibitors: The Effectiveness of Complementary Treatment with Clostridium butyricum 588Massimiliano Cazzaniga, Alexander Bertuccioli, Ilaria Cavecchia et al.|Microorganisms|2024Cited by 15
Irritable Bowel Syndrome with Diarrhea (IBS-D): Effects of Clostridium butyricum CBM588 Probiotic on Gastrointestinal Symptoms, Quality of Life, and Gut Microbiota in a Prospective Real-Life Interventional StudyFrancesco Di Pierro, Nicola Zerbinati, Francesca Menasci et al.|Microorganisms|2025Cited by 8
Sports-Related Gastrointestinal Disorders: From the Microbiota to the Possible Role of Nutraceuticals, a Narrative AnalysisAlexander Bertuccioli, Chiara Maria Palazzi, Giordano Bruno Zonzini et al.|Microorganisms|2024Cited by 7
The Anti-Constipation Effect of Bifidobacterium Longum W11 Is Likely Due to a Key Genetic Factor Governing Arabinan UtilizationFrancesco Di Pierro, Sara Soldi, Nicola Zerbinati et al.|Microorganisms|2024Cited by 5
The Role of Targeted Microbiota Therapy in the Prevention and Management of Puerperal MastitisMariarosaria Matera, Ilaria Cavecchia, Chiara Maria Palazzi et al.|Diseases|2025Cited by 4